SSY Group Limited
2005.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.71B
Close$
Share Statistics
| Market cap | $7.71 Billion |
|---|---|
| Enterprise Value | $9.82 Billion |
| Dividend Yield | $0.08 (3.19%) |
| Earnings per Share | $0.16 |
| Beta | 0.51 |
| Outstanding Shares | 2,893,862,000 |
Return
| Return on Equity | 14.95% |
|---|---|
| Return on Assets | 8.66% |
| Return on Invested Capital | 13.12% |
Valuation & Multiples
| P/E Ratio | 15.31 |
|---|---|
| PEG | 118.14 |
| Price to Sales | 0.89 |
| Price to Book Ratio | 1.33 |
| Enterprise Value to Revenue | 1.1 |
| Enterprise Value to EBIT | 7.02 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$2.36 B
Average shareholder expectationNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$2.31 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SSY Group Limited
5,400 employees
CEO: Ji Guang Qu SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company o...